Login / Signup

Improving drug discovery through parallelism.

Jerónimo S GarcíaSavíns Puertas-MartínJuana L RedondoJuan José MorenoPilar M Ortigosa
Published in: The Journal of supercomputing (2023)
Compound identification in ligand-based virtual screening is limited by two key issues: the quality and the time needed to obtain predictions. In this sense, we designed OptiPharm, an algorithm that obtained excellent results in improving the sequential methods in the literature. In this work, we go a step further and propose its parallelization. Specifically, we propose a two-layer parallelization. Firstly, an automation of the molecule distribution process between the available nodes in a cluster, and secondly, a parallelization of the internal methods (initialization, reproduction, selection and optimization). This new software, called pOptiPharm, aims to improve the quality of predictions and reduce experimentation time. As the results show, the performance of the proposed methods is good. It can find better solutions than the sequential OptiPharm, all while reducing its computation time almost proportionally to the number of processing units considered.
Keyphrases
  • drug discovery
  • systematic review
  • machine learning
  • quality improvement
  • deep learning
  • squamous cell carcinoma
  • early stage
  • radiation therapy